PreDiabetes Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

PreDiabetes pipeline constitutes 15+ key companies continuously working towards developing 15+ PreDiabetes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

PreDiabetes Overview
PreDiabetes is a metabolic disorder that is considered as a precursor for the development of diabetes mellitus. It is characterized by higher than normal blood glucose levels that has not yet reached diabetic levels. The exact cause of prediabetes is unknown, but family history and genetics appear to play an important role. A lack of regular physical activity and being overweight with excess fat also seem to be an important factors. Prediabetic persons also doesn't make or use the hormone insulin properly, as a result, too much glucose builds up in the bloodstream. This buildup of sugar in the blood causes prediabetes.

"PreDiabetes Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the PreDiabetes Market.

The PreDiabetes Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the PreDiabetes Pipeline Report: https://www.delveinsight.com/report-store/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Companies across the globe are diligently working toward developing novel PreDiabetes treatment therapies with a considerable amount of success over the years. PreDiabetes Key players such as - NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharmaceutical Group Co., Ltd., Valbiotis, and others, are developing therapies for the PreDiabetes treatment
PreDiabetes Emerging therapies such as - OKV-119, Anaerostipes rhamnosivorans, Intestinimonas, INV-202, HSK7653, Eubacterium Hallii, Totum-63, and others are expected to have a significant impact on the PreDiabetes market in the coming years.
In July 2020, Valbiotis initiated a trial titled, "Randomized Placebo-controlled Double-blinded Study of the Effect of TOTUM-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia'. This clinical study aims to assess the efficacy of TOTUM-63, a mix of 5 plant extracts, consumed at the daily regimen of three times per day on glucose and lipidhomeostasis in dysglycemic subjects

PreDiabetes Pipeline Therapeutics Assessment
PreDiabetes Assessment by Product Type
PreDiabetes By Stage and Product Type
PreDiabetes Assessment by Route of Administration
PreDiabetes By Stage and Route of Administration
PreDiabetes Assessment by Molecule Type
PreDiabetes by Stage and Molecule Type

DelveInsight's PreDiabetes Report covers around 15+ products under different phases of clinical development like
Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Emerging PreDiabetes Drugs Under Different Phases of Clinical Development Include:
OKV-119: NanoPrecision Medical
Anaerostipes rhamnosivorans: Caelus Health
Intestinimonas: Caelus Health
INV-202: Inversago Pharma Inc.
HSK7653: Haisco Pharmaceutical Group Co., Ltd.
Eubacterium Hallii: Caelus Health
Totum-63: Valbiotis

Get a Free Sample PDF Report to know more about PreDiabetes Pipeline Assessment- https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

PreDiabetes Pipeline Analysis:
The PreDiabetes pipeline report provides insights into
The report provides detailed insights about companies that are developing therapies for the PreDiabetes treatment with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for PreDiabetes Treatment.
PreDiabetes key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
PreDiabetes Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the PreDiabetes market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Further PreDiabetes product details are provided in the report. Download the PreDiabetes pipeline report to learn more about the emerging PreDiabetes therapies at:
https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

PreDiabetes Pipeline Market Drivers
Increase in prevalence of prediabetes
Increase in Diagnosis and Growing investments in research and development

PreDiabetes Pipeline Market Barriers
Side effects associated with Drugs
Lack of Awareness among Patients

Scope of PreDiabetes Pipeline Drug Insight
Coverage: Global
Key PreDiabetes Companies: NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharmaceutical Group Co., Ltd., Valbiotis, and others
Key PreDiabetes Therapies: OKV-119, Anaerostipes rhamnosivorans, Intestinimonas, INV-202, HSK7653, Eubacterium Hallii, Totum-63, and others
PreDiabetes Therapeutic Assessment: PreDiabetes current marketed and PreDiabetes emerging therapies
PreDiabetes Market Dynamics: PreDiabetes market drivers and PreDiabetes market barriers

Request for Sample PDF Report for PreDiabetes Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1
PreDiabetes Report Introduction
2
PreDiabetes Executive Summary
3
PreDiabetes Overview
4
PreDiabetes- Analytical Perspective In-depth Commercial Assessment
5
PreDiabetes Pipeline Therapeutics
6
PreDiabetes Late Stage Products (Phase II/III)
7
PreDiabetes Mid Stage Products (Phase II)
8
PreDiabetes Early Stage Products (Phase I)
9
PreDiabetes Preclinical Stage Products
10
PreDiabetes Therapeutics Assessment
11
PreDiabetes Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
PreDiabetes Key Companies
14
PreDiabetes Key Products
15
PreDiabetes Unmet Needs
16
PreDiabetes Market Drivers and Barriers
17
PreDiabetes Future Perspectives and Conclusion
18
PreDiabetes Analyst Views
19
Appendix
20
About DelveInsight

Download Sample PDF Report to know more about PreDiabetes drugs and therapies- https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Related Reports:

PreDiabetes Market https://www.delveinsight.com/report-store/prediabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'PreDiabetes-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

PreDiabetes Epidemiology https://www.delveinsight.com/report-store/prediabetes-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'PreDiabetes Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact

Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.